<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gastro-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал гастроэнтерологии, гепатологии, колопроктологии</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Gastroenterology, Hepatology, Coloproctology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1382-4376</issn><issn pub-type="epub">2658-6673</issn><publisher><publisher-name>«Gastro» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22416/1382-4376-2016-4-124-128</article-id><article-id custom-type="elpub" pub-id-type="custom">gastro-j-76</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НОВОСТИ КОЛОПРОКТОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NEWS OF COLOPROCTOLOGY</subject></subj-group></article-categories><title-group><article-title>Новые Римские критерии функциональной диспепсии IV пересмотра</article-title><trans-title-group xml:lang="en"><trans-title>New Rome-IV criteria of the functional dyspepsia (review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шептулин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sheptulin</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">arkalshep@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курбатова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurbatova</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>12</day><month>08</month><year>2018</year></pub-date><volume>26</volume><issue>4</issue><fpage>124</fpage><lpage>128</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шептулин А.А., Курбатова А.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Шептулин А.А., Курбатова А.А.</copyright-holder><copyright-holder xml:lang="en">Sheptulin A.A., Kurbatova A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gastro-j.ru/jour/article/view/76">https://www.gastro-j.ru/jour/article/view/76</self-uri><abstract><p>Цель обзора. Провести анализ изменений, внесенных в Римские критерии функциональной диспепсии (ФД) IV пересмотра по сравнению с предшествующими критериями. Основные положения. Определение ФД и ее основных вариантов - постпрандиального дистресс-синдрома (ПДС) и синдрома боли в эпигастрии (СБЭ) в новых критериях не претерпело больших изменений по сравнению с предыдущими. Показано частое сочетание ПДС и СБЭ между собой, с такими симптомами, как тошнота и отрыжка, и рядом других заболеваний: гастроэзофагеальной рефлюксной болезнью и синдромом раздраженного кишечника. Диагноз ФД, по-прежнему, рекомендовано ставить, ориентируясь на соответствие жалоб больного Римским критериям и отсутствие симптомов тревоги. Основное место в лечении ПДС занимают прокинетики, в терапии СБЭ - антисекреторные препараты. Заключение. Римские критерии ФД IV пересмотра имеют определенные преимущества по сравнению с предыдущими критериями, но в то же время сохраняют существенные недостатки.</p></abstract><trans-abstract xml:lang="en"><p>Aim of review. To analyze the changes in the IV revision of Rome criteria of the functional dyspepsia (FD) in comparison to existing criteria. Key points. The definition of FD and its main variants - postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) in new criteria did not undergo major changes in comparison to previous edition. Frequent combination of PDS and EPS both with each other, with such symptoms as nausea and belching and some other diseases as gastroesophageal reflux disease and irritable bowel syndrome was demonstrated. It is, still, recommended to make the diagnosis of FD, being guided both by compliance of patients symptoms to Rome criteria and the absence of alarm symptoms. The major place in the treatment of PDS is occupied by prokinetics, in EPS treatment - by antisecretory medications. Conclusion. The fourth revision of Rome criteria of FD have certain advantages in comparison to the previous criteria, but at the same time preserve essential shortcomings.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Римские критерии IV пересмотра</kwd><kwd>функциональная диспепсия</kwd><kwd>дефиниция</kwd><kwd>патофизиология</kwd><kwd>диагностика</kwd><kwd>лечение</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Шептулин А.А., Лапина Т.Л. и др. Диагностика и лечение функциональной диспепсии. Методические рекомендации Российской гастроэнтерологической ассоциации для врачей. М., 2011. 28 с.</mixed-citation><mixed-citation xml:lang="en">Ивашкин В.Т., Шептулин А.А., Лапина Т.Л. и др. Диагностика и лечение функциональной диспепсии. Методические рекомендации Российской гастроэнтерологической ассоциации для врачей. М., 2011. 28 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Drossman D.A., Hasler W.L. Rome IV Functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016; 150(6):1257-61.</mixed-citation><mixed-citation xml:lang="en">Drossman D.A., Hasler W.L. Rome IV Functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016; 150(6):1257-61.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Holtmann G., Nandurkar S., Talley N.J., et al. Herbal medicine for the treatment of functional dyspepsia: a systematic review of the literature and meta-analysis. Gastroenterology 2007; suppl. 2. Abstract W1204.</mixed-citation><mixed-citation xml:lang="en">Holtmann G., Nandurkar S., Talley N.J., et al. Herbal medicine for the treatment of functional dyspepsia: a systematic review of the literature and meta-analysis. Gastroenterology 2007; suppl. 2. Abstract W1204.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Houghton L.A., Heitkemper M., Crowell M.D., et al. Age, gender and women’s health and patient. Gastroenterology 2016; 150(6):1332-43.</mixed-citation><mixed-citation xml:lang="en">Houghton L.A., Heitkemper M., Crowell M.D., et al. Age, gender and women’s health and patient. Gastroenterology 2016; 150(6):1332-43.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Madisch A., Holtmann G., Plein K., Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19:271-9.</mixed-citation><mixed-citation xml:lang="en">Madisch A., Holtmann G., Plein K., Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19:271-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ottilinger B., Storr M., Malfertheiner P., Allescher H.-D. STW 5 (Iberogast®) - a safe and effective standart in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr 2013; 163:65-72.</mixed-citation><mixed-citation xml:lang="en">Ottilinger B., Storr M., Malfertheiner P., Allescher H.-D. STW 5 (Iberogast®) - a safe and effective standart in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr 2013; 163:65-72.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stanghellini V., Chan F.C.L., Hasler W.L., et al. Gastroduodenal disorders. Gastroenterology 2016; 150(6):1380-92.</mixed-citation><mixed-citation xml:lang="en">Stanghellini V., Chan F.C.L., Hasler W.L., et al. Gastroduodenal disorders. Gastroenterology 2016; 150(6):1380-92.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sugano K., Tack J., Kuipers E.J., et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64:133-67.</mixed-citation><mixed-citation xml:lang="en">Sugano K., Tack J., Kuipers E.J., et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64:133-67.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466-79.</mixed-citation><mixed-citation xml:lang="en">Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466-79.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Talley N.J. Dyspepsia: How to sort out the mess? Dig Dis Week, San Diego, 2016. Oral presentation.</mixed-citation><mixed-citation xml:lang="en">Talley N.J. Dyspepsia: How to sort out the mess? Dig Dis Week, San Diego, 2016. Oral presentation.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Talley N.J. Functional ghastroduodenal disorders // AGA Institute-Rome Foundation lectureship: the launching of Rome IV: what’s new and why? Dig Dis Week, San Diego, 2016. Oral presentation.</mixed-citation><mixed-citation xml:lang="en">Talley N.J. Functional ghastroduodenal disorders // AGA Institute-Rome Foundation lectureship: the launching of Rome IV: what’s new and why? Dig Dis Week, San Diego, 2016. Oral presentation.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Talley N.J., Locke G.R., Saito Y.A., et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology 2015; 149:340-9.</mixed-citation><mixed-citation xml:lang="en">Talley N.J., Locke G.R., Saito Y.A., et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology 2015; 149:340-9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
